Max Healthcare Q1 Results 2027: Revenue Rises 17% YoY, PAT Increases 5% to ₹323 Cr
Max Healthcare reported 17% YoY revenue growth in Q1 FY27, while PAT rose 5% to ₹323 crore. EBITDA increased 14% YoY, although EBITDA and PAT margins declined from the previous quarter.
Max Healthcare Q1 Results FY2027: Max Healthcare reported 16.70% YoY revenue growth to ₹2,366 crore in Q1 FY27. PAT increased 4.87% to ₹323 crore, while EBITDA rose 14.44% to ₹598 crore. However, EBITDA and PAT margins declined compared with the previous quarter.
Max Healthcare Q1 Results FY2027: On 13 August 2026, Max Healthcare Institute announced its financial results for the first quarter ended 30 June 2026. Revenue from Operations increased 16.70% YoY to ₹2,366 crore compared with ₹2,028 crore in Q1 FY26.
While Profit After Tax (PAT) stood at ₹323 crore compared with ₹308 crore in Q1 FY26, registering a 4.87% YoY increase. EBITDA Margin stood at 25.30% during the quarter.
Max Healthcare share price is trading 0.32% lower on 13 August 2026 at the time of writing. The stock has delivered -4% returns year-to-date and -21% returns over the one-year period from 13 August 2025 to 13 August 2026.
As of 13 Aug, 3:12 PM
Max Healthcare Q1 FY27 Results Highlights
-
Revenue from Operations stood at ₹2,366 crore, registering a 16.70% YoY increase from ₹2,028 crore in Q1 FY26. Compared with ₹2,143 crore in Q4 FY26, revenue increased 10.42% QoQ.
-
Total Revenue stood at ₹2,407 crore, registering a 16.60% YoY increase from ₹2,064 crore in Q1 FY26. Compared with ₹2,191 crore in Q4 FY26, total revenue increased 9.86% QoQ.
-
EBITDA (Excluding Other Income) stood at ₹598 crore, compared with ₹523 crore in Q1 FY26, registering a 14.44% YoY increase. Compared with ₹606 crore in Q4 FY26, EBITDA declined 1.32% QoQ.
-
EBITDA Margin stood at 25.30%, compared with 25.80% in Q1 FY26 and 28.30% in Q4 FY26, declining by 0.50 percentage points YoY and 3.00 percentage points QoQ.
-
Profit After Tax (PAT) stood at ₹323 crore, compared with ₹308 crore in Q1 FY26, with the profit increasing by 4.87% YoY. Compared with ₹342 crore in Q4 FY26, PAT declined 5.63% QoQ.
-
PAT Margin stood at 13.60%, compared with 15.20% in Q1 FY26 and 16.00% in Q4 FY26, declining by 1.60 percentage points YoY and 2.40 percentage points QoQ.
READ THIS: Anant Raj Q1 Results 2027
Max Healthcare Q1 FY27 Financial Summary
|
Metric |
Q1 FY27 |
Q4 FY26 |
QoQ % |
Q1 FY26 |
YoY % |
|---|---|---|---|---|---|
|
Revenue from Operations (₹ Cr) |
2,366 |
2,143 |
10.42% |
2,028 |
16.70% |
|
Total Revenue (₹ Cr) |
2,407 |
2,191 |
9.86% |
2,064 |
16.60% |
|
EBITDA (Excl. Other Income) (₹ Cr) |
598 |
606 |
-1.32% |
523 |
14.44% |
|
EBITDA Margin |
25.30% |
28.30% |
-3.00 pp |
25.80% |
-0.50 pp |
|
PAT (₹ Cr) |
323 |
342 |
-5.63% |
308 |
4.87% |
|
PAT Margin |
13.60% |
16.00% |
-2.40 pp |
15.20% |
-1.60 pp |
|
EPS (₹) |
3.32 |
3.52 |
-5.68% |
3.17 |
4.73% |
Source: Company Filing
All topics
Click the link, confirm the box next to sahi.com is checked — ignore any other results.